Home Health Care News June 21, 2022
In November, MedArrive had a significant jumping-off point established. It was worth $25 million, raised through a Series A and led by the venture capital fund Section 32.
Its goal was to make “tens of thousands” of at-home visits in the next year, CEO Dan Trigub told Home Health Care News at the time.
It has found multiple ways to do just that. But like many other home-based care companies, it’s also used COVID-19 as a jumping off point. For instance, a recent partnership with the health plan Health Net has allowed it to vaccinate more individuals from the virus in their homes.
That allows MedArrive to vaccinate vulnerable individuals, for one, but it also sets them up to eventually...